<html>

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=Generator content="Microsoft Word 15 (filtered)">
<title>AR110</title>
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:"Albertus Extra Bold";
	panose-1:2 14 8 2 4 3 4 2 2 4;}
@font-face
	{font-family:Marlett;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
	{font-family:"Segoe UI";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{margin:0in;
	margin-bottom:.0001pt;
	font-size:9.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.MsoDocumentMap, li.MsoDocumentMap, div.MsoDocumentMap
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	background:navy;
	font-size:12.0pt;
	font-family:"Tahoma",sans-serif;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{mso-style-link:"Balloon Text Char";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:9.0pt;
	font-family:"Segoe UI",sans-serif;
	letter-spacing:.2pt;}
span.11ptChar
	{mso-style-name:11ptChar;
	font-family:"Times New Roman",serif;}
span.BillHead
	{mso-style-name:BillHead;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;
	font-weight:bold;}
span.BillHeading2
	{mso-style-name:BillHeading2;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;
	font-weight:bold;}
span.BillHeadUnBold
	{mso-style-name:BillHeadUnBold;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;}
span.BillLanguage
	{mso-style-name:BillLanguage;
	font-family:"Times New Roman",serif;
	font-style:italic;}
p.bpuBill, li.bpuBill, div.bpuBill
	{mso-style-name:bpuBill;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:26.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuHeadSpon, li.bpuHeadSpon, div.bpuHeadSpon
	{mso-style-name:bpuHeadSpon;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
span.bpuHeadSponChar
	{mso-style-name:bpuHeadSponChar;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuIntro, li.bpuIntro, div.bpuIntro
	{mso-style-name:bpuIntro;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.bpuLegislature, li.bpuLegislature, div.bpuLegislature
	{mso-style-name:bpuLegislature;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:24.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuNormText, li.bpuNormText, div.bpuNormText
	{mso-style-name:bpuNormText;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.bpuReprint, li.bpuReprint, div.bpuReprint
	{mso-style-name:bpuReprint;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:22.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.bpuSponsor, li.bpuSponsor, div.bpuSponsor
	{mso-style-name:bpuSponsor;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuState, li.bpuState, div.bpuState
	{mso-style-name:bpuState;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:32.0pt;
	font-family:"Arial",sans-serif;
	font-weight:bold;}
span.charMarlett
	{mso-style-name:charMarlett;
	font-family:Marlett;}
p.ElevenPt, li.ElevenPt, div.ElevenPt
	{mso-style-name:ElevenPt;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPage, li.FronterPage, div.FronterPage
	{mso-style-name:FronterPage;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPage12pt, li.FronterPage12pt, div.FronterPage12pt
	{mso-style-name:FronterPage12pt;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPageBillHeading, li.FronterPageBillHeading, div.FronterPageBillHeading
	{mso-style-name:FronterPageBillHeading;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;}
p.FronterPageTBox2, li.FronterPageTBox2, div.FronterPageTBox2
	{mso-style-name:FronterPageTBox2;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPageTextBox, li.FronterPageTextBox, div.FronterPageTextBox
	{mso-style-name:FronterPageTextBox;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.FronterSameAs, li.FronterSameAs, div.FronterSameAs
	{mso-style-name:FronterSameAs;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.HangingAnAct, li.HangingAnAct, div.HangingAnAct
	{mso-style-name:HangingAnAct;
	mso-style-link:"HangingAnAct Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.HangingAnActChar
	{mso-style-name:"HangingAnAct Char";
	mso-style-link:HangingAnAct;
	letter-spacing:.2pt;}
span.Para10pt
	{mso-style-name:Para10pt;
	font-family:"Times New Roman",serif;}
p.Pg2Footer, li.Pg2Footer, div.Pg2Footer
	{mso-style-name:Pg2Footer;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:8.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.StyleFronterPage11pt, li.StyleFronterPage11pt, div.StyleFronterPage11pt
	{mso-style-name:"Style FronterPage + 11 pt";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.StyleFronterPageLoweredby3pt, li.StyleFronterPageLoweredby3pt, div.StyleFronterPageLoweredby3pt
	{mso-style-name:"Style FronterPage + Lowered by  3 pt";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	position:relative;
	top:3.0pt;}
p.StyleFronterSameAsPatternSolid100White, li.StyleFronterSameAsPatternSolid100White, div.StyleFronterSameAsPatternSolid100White
	{mso-style-name:"Style FronterSameAs + Pattern\: Solid \(100%\) \(White\)";
	margin:0in;
	margin-bottom:.0001pt;
	background:white;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.Style1, li.Style1, div.Style1
	{mso-style-name:Style1;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
span.Whereas
	{mso-style-name:Whereas;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;
	font-weight:bold;}
span.Style10pt
	{mso-style-name:"Style 10 pt";
	font-family:"Times New Roman",serif;}
p.FronterPageNOCAPS, li.FronterPageNOCAPS, div.FronterPageNOCAPS
	{mso-style-name:FronterPageNOCAPS;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.bpuWpGraphic, li.bpuWpGraphic, div.bpuWpGraphic
	{mso-style-name:bpuWpGraphic;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.sponUdate, li.sponUdate, div.sponUdate
	{mso-style-name:sponUdate;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
span.fronterpagebillhead
	{mso-style-name:fronterpagebillhead;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;}
p.FPHangingAnAct, li.FPHangingAnAct, div.FPHangingAnAct
	{mso-style-name:FPHangingAnAct;
	mso-style-link:"FPHangingAnAct Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.4in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.FPHangingAnActChar
	{mso-style-name:"FPHangingAnAct Char";
	mso-style-link:FPHangingAnAct;
	letter-spacing:.2pt;}
span.LeftBrackt
	{mso-style-name:LeftBrackt;
	font-family:"Albertus Extra Bold",sans-serif;
	font-weight:bold;}
span.RightBrackt
	{mso-style-name:RightBrackt;
	font-family:"Albertus Extra Bold",sans-serif;
	font-weight:bold;}
span.BoldItal
	{mso-style-name:BoldItal;
	font-weight:bold;
	font-style:italic;}
p.HangingSup, li.HangingSup, div.HangingSup
	{mso-style-name:HangingSup;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.HangingTableBottom, li.HangingTableBottom, div.HangingTableBottom
	{mso-style-name:HangingTableBottom;
	margin-top:0in;
	margin-right:1.0in;
	margin-bottom:0in;
	margin-left:.8in;
	margin-bottom:.0001pt;
	text-indent:-.8in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.HangingTableTop, li.HangingTableTop, div.HangingTableTop
	{mso-style-name:HangingTableTop;
	margin-top:0in;
	margin-right:.5in;
	margin-bottom:0in;
	margin-left:.8in;
	margin-bottom:.0001pt;
	text-indent:-.8in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.BalloonTextChar
	{mso-style-name:"Balloon Text Char";
	mso-style-link:"Balloon Text";
	font-family:"Segoe UI",sans-serif;
	letter-spacing:.2pt;}
.MsoChpDefault
	{font-size:10.0pt;}
 /* Page Definitions */
 @page WordSection1
	{size:8.5in 14.0in;
	margin:1.5in 1.0in 1.0in 1.0in;}
div.WordSection1
	{page:WordSection1;}
@page WordSection2
	{size:8.5in 14.0in;
	margin:1.0in 113.75pt 1.0in 113.75pt;}
div.WordSection2
	{page:WordSection2;}
@page WordSection3
	{size:8.5in 14.0in;
	margin:1.0in 1.75in 1.3in 2.0in;}
div.WordSection3
	{page:WordSection3;}
-->
</style>

</head>

<body lang=EN-US>

<div class=WordSection1>

<p class=bpuBill><a name=bpuFrontPg></a>ASSEMBLY RESOLUTION No. 110 </p>

<p class=bpuWpGraphic><b><span style='font-size:32.0pt;line-height:120%;
font-family:"Arial",sans-serif;letter-spacing:0pt'>STATE OF NEW JERSEY</span></b></p>

<p class=bpuLegislature>221st LEGISLATURE</p>

<p class=bpuWpGraphic>  </p>

<p class=bpuIntro>INTRODUCED FEBRUARY 22, 2024</p>

<p class=bpuIntro>&nbsp;</p>

</div>

<span style='font-size:11.0pt;line-height:120%;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:auto'>
</span>

<div class=WordSection2>

<p class=bpuIntro>&nbsp;</p>

<p class=bpuSponsor>Sponsored by:</p>

<p class=bpuSponsor>Assemblywoman  CAROL A. MURPHY</p>

<p class=bpuSponsor>District 7 (Burlington)</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>SYNOPSIS</p>

<p class=bpuNormText>     Urges President and Congress to enact &quot;Humane
Cosmetics Act of 2023.&quot; </p>

<p class=bpuNormText>&nbsp;</p>

<p class=bpuSponsor>CURRENT VERSION OF TEXT </p>

<p class=bpuNormText>     As introduced.</p>

<p class=bpuNormText>   </p>

</div>

<span style='font-size:12.0pt;line-height:120%;font-family:"Times New Roman",serif;
letter-spacing:.2pt'><br clear=all style='page-break-before:always'>
</span>

<div class=WordSection3>

<p class=HangingAnAct style='line-height:150%'><span class=BillHead>An Assembly
Resolution</span><span class=HangingAnActChar> </span>urging the President and
Congress of the United States to enact the Humane Cosmetics Act of 2023,
concerning cosmetics testing on animals.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='margin-left:.2in;text-indent:-.2in;line-height:150%'><b><span
style='font-variant:small-caps;letter-spacing:0pt'>Whereas,</span></b><span
style='letter-spacing:0pt'> Every year, countless animals are injured and
killed in tests that attempt to evaluate the hazards of consumer products and
their ingredients; and</span></p>

<p class=MsoNormal style='margin-left:.2in;text-indent:-.2in;line-height:150%'><b><span
style='font-variant:small-caps;letter-spacing:0pt'>Whereas,</span></b><span
style='letter-spacing:0pt'> In an effort to measure toxicity, rats, mice,
guinea pigs, rabbits, and other animals are forced to swallow or inhale massive
quantities of test substances or have a chemical spread in their eyes or on
their skin; and</span></p>

<p class=MsoNormal style='margin-left:.2in;text-indent:-.2in;line-height:150%'><b><span
style='font-variant:small-caps;letter-spacing:0pt'>Whereas,</span></b><span
style='letter-spacing:0pt'> Tests on animals often do not predict outcomes in
humans, and many non-animal test methods are available and continue to be developed;
and</span></p>

<p class=MsoNormal style='margin-left:.2in;text-indent:-.2in;line-height:150%'><b><span
style='font-variant:small-caps;letter-spacing:0pt'>Whereas,</span></b><span
style='letter-spacing:0pt'> Acute toxicity testing, eye and skin irritation
testing, skin sensitization testing, carcinogenicity testing, and reproductive
and developmental toxicity testing cause great pain to animals without
necessarily providing more accurate conclusions about the safety of consumer
products than non-animal testing alternatives; and</span></p>

<p class=MsoNormal style='margin-left:.2in;text-indent:-.2in;line-height:150%'><b><span
style='font-variant:small-caps;letter-spacing:0pt'>Whereas,</span></b><span
style='letter-spacing:0pt'> The United States Food and Drug Administration
advises cosmetics manufacturers to employ whatever testing is appropriate and
effective for substantiating the safety of their products while noting that the
federal Food, Drug, and Cosmetic Act does not specifically require the use of
animals in testing cosmetics for safety; and</span></p>

<p class=MsoNormal style='margin-left:.2in;text-indent:-.2in;line-height:150%'><b><span
style='font-variant:small-caps;letter-spacing:0pt'>Whereas,</span></b><span
style='letter-spacing:0pt'> The United States Consumer Product Safety
Commissions animal testing policy states that neither the Federal Hazardous
Substances Act nor the commissions regulations require animal testing and only
require that a product be labeled to reflect the hazards associated with that
product; and</span></p>

<p class=MsoNormal style='margin-left:.2in;text-indent:-.2in;line-height:150%'><b><span
style='font-variant:small-caps;letter-spacing:0pt'>Whereas,</span></b><span
style='letter-spacing:0pt'> While some countries, such as China, require
specific animal tests for these products, the European Union, Israel, and India
have banned the sale of any cosmetics or cosmetics ingredients that have been
tested on animals; and</span></p>

<p class=MsoNormal style='margin-left:.2in;text-indent:-.2in;line-height:150%'><b><span
style='font-variant:small-caps;letter-spacing:0pt'>Whereas,</span></b><span
style='letter-spacing:0pt'> The Humane Cosmetics Act of 2023, was introduced
on September 12, 2023 as H.R.5399, and if enacted, would prohibit testing
cosmetics on animals, as well as the sale or transport of any cosmetics in
interstate commerce if any component of the final product was developed or
manufactured using animal testing; and </span></p>

<p class=MsoNormal style='margin-left:.2in;text-indent:-.2in;line-height:150%'><b><span
style='font-variant:small-caps;letter-spacing:0pt'>Whereas,</span></b><span
style='letter-spacing:0pt'> Banning animal testing in the United States and
prohibiting the sale and transport of products that have been tested on animals
would help reduce animal cosmetics testing worldwide; and</span></p>

<p class=MsoNormal style='margin-left:.2in;text-indent:-.2in;line-height:150%'><b><span
style='font-variant:small-caps;letter-spacing:0pt'>Whereas,</span></b><span
style='letter-spacing:0pt'> The cosmetics industry already has safer, more cost-effective
methods of testing that do not harm animals and American companies face no
economic risk from this legislation; and</span></p>

<p class=MsoNormal style='margin-left:.2in;text-indent:-.2in;line-height:150%'><b><span
style='font-variant:small-caps;letter-spacing:0pt'>Whereas,</span></b><span
style='letter-spacing:0pt'> The cosmetics industry is already using alternative
cutting-edge testing methods that are safer and cheaper and which do not hurt
animals, and the United States should show moral leadership by standing against
the inhumane treatment of animals; and</span></p>

<p class=MsoNormal style='margin-left:.2in;text-indent:-.2in;line-height:150%'><b><span
style='font-variant:small-caps;letter-spacing:0pt'>Whereas,</span></b><span
style='letter-spacing:0pt'> If enacted, the Humane Cosmetics Act of 2023
would bring the United States cosmetics policy in line with more than 30
countries that have already implemented bans on animal testing and the sale of
animal-tested cosmetics, including the European Union, Israel, Norway,
Switzerland, and India; and</span></p>

<p class=MsoNormal style='margin-left:.2in;text-indent:-.2in;line-height:150%'><b><span
style='font-variant:small-caps;letter-spacing:0pt'>Whereas,</span></b><span
style='letter-spacing:0pt'> Of the 13 biggest importers of American cosmetics,
eight countries have bans in place or legislation under consideration regarding
animal testing, and American cosmetics companies already have to comply with
these animal testing bans; and</span></p>

<p class=MsoNormal style='margin-left:.2in;text-indent:-.2in;line-height:150%'><b><span
style='font-variant:small-caps;letter-spacing:0pt'>Whereas,</span></b><span
style='letter-spacing:0pt'> Seven hundred cosmetics brands in North America do
not test products or ingredients on animals, and instead use other affordable,
proven methods of testing and innovate with thousands of ingredients already
proven safe for use; and</span></p>

<p class=MsoNormal style='margin-left:.2in;text-indent:-.2in;line-height:150%'><b><span
style='font-variant:small-caps;letter-spacing:0pt'>Whereas,</span></b><span
style='letter-spacing:0pt'> The Humane Cosmetics Act of 2023 is endorsed by over
370 companies in the cosmetics industry, and is supported by both Republican
and Democratic cosponsors; now, therefore, </span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:150%'>      <span class=BillHeading2>Be
It Resolved </span><span class=BillLanguage>by the General Assembly of the
State of New Jersey:</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      1.   This
House urges the President and Congress of the United States to enact H.R.5399
of the 118<sup>th</sup> Congress, known as the Humane Cosmetics Act of 2023,
to ban the testing of cosmetics on animals and the sale of any cosmetics
product that uses animal testing.</span></p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     2.    Copies of this
resolution, as filed with the Secretary of State, shall be transmitted by the
Clerk of the General Assembly to the President of the United States, the
Majority and Minority Leaders of the United States Senate, the Speaker and
Minority Leader of the United States House of Representatives, and every member
of the congressional delegation from the State of New Jersey.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal align=center style='text-align:center;line-height:150%'>STATEMENT</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     This bill urges the President
and Congress to enact the Humane Cosmetics Act of 2023, which would prohibit
testing cosmetics on animals, as well as the sale or transport of a cosmetic in
interstate commerce, if any component of the cosmetic was developed or
manufactured using animal testing.  The bill was introduced in the 118th
Congress as H.R.5399.</p>

<p class=MsoNormal style='line-height:150%'>     Every year, countless animals
are poisoned and killed in tests that attempt to evaluate the hazards of
consumer products and their ingredients.  Despite the widespread availability
of effective alternatives to animal testing, many cosmetics companies still
conduct testing on animals.  By banning animal testing in the United States,
and prohibiting the sale of products that have been tested on animals, the
enactment of this legislation would help reduce animal cosmetics testing
worldwide, and bring the United States cosmetics policy in line with more than
30 countries that have already implemented bans on the sale of animal-tested
cosmetics, including the European Union, Israel, Norway, Switzerland, and
India.</p>

<p class=MsoNormal style='line-height:150%'>     The &quot;Humane Cosmetics Act
of 2023&quot; is endorsed by over 370 companies in the cosmetics industry, and
is supported by both Republican and Democratic cosponsors.  By enacting this
legislation, the United States can show moral leadership without compromising
product safety or business profitability.</p>

</div>

</body>

</html>
